DGAP-News: mutares sells Suir Pharma Ireland DGAP-News:

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-News: mutares sells Suir Pharma Ireland

DGAP-News: mutares AG / Key word(s): Mergers & Acquisitions/Private Equity mutares sells Suir Pharma Ireland 23.06.2015 / 09:40 --------------------------------------------------------------------- The Munich-based restructuring specialist mutares AG (ISIN: DE000A0SMSH2) has sold the pharmaceutical contract manufacturer Suir Pharma Ireland to the strategic investor Saneca Pharmaceuticals. With its second successful exit in 2015, mutares further streamlines its portfolio. Suir Pharma Ireland (SPI) was acquired in 2012 from German STADA Group. It operates as a Contract Manufacturing Organisation (CMO) producing finished dosage formulations across a broad range of therapeutic areas for various customers worldwide and operates the only Independent Beta-Lactam FDA approved facility in Europe. After successfully accomplishing the main challenge of making SPI a stand-alone pharmaceutical contract manufacturer, mutares has decided to sell SPI to Saneca Pharmaceuticals for an undisclosed amount. Hence, mutares continues to streamline its portfolio and to free up capacities for new transactions as the deal pipeline is very promising. Saneca Pharmaceuticals is confident that this strategic acquisition will add significantly to the services that the Saneca Group can offer to its customers. Lubo Soltys, President of Saneca, commented: "We are delighted to have acquired Suir Pharma. We see the combined entity providing significantly enhanced pharmaceutical development capacity and tech transfer capabilities across a range of pharmaceutical forms. This will certainly provide easier access to various markets for our worldwide customer base." Company profile of Saneca Pharmaceuticals Saneca Pharmaceuticals is a supplier to the global pharmaceutical and healthcare industry. Saneca develops and produces high quality pharmaceutical dosage forms, including oral solid, liquids, soft gel capsules and creams. In addition, Saneca Pharmaceuticals has a portfolio of synthetic API's, and opiate API's produced from plant biomass. Company profile of mutares AG mutares AG, Munich (www.mutares.de), acquires companies, that are being sold in the course of a repositioning process at their owners and that show a clear operational improvement potential. Getting engaged with its own teams, mutares actively supports its portfolio companies to achieve a clear value increase. The focus of the operational work is to ensure sustainable, long-term growth. The shares of mutares AG are traded in the Open Market of the Frankfurt Stock Exchange (Entry Standard) under the symbol MUX (ISIN: DE000A0SMSH2). For further information, please contact: mutares AG Christoph Himmel Investor Relations & Corporate Communications Tel. +49 89 9292776-0 Fax +49 89 9292776-22 ir@mutares.de www.mutares.de --------------------------------------------------------------------- 23.06.2015 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- 370845 23.06.2015

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 7

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 7

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 9

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 11

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 5

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 4

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 10

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 6

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 11

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 10

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading

Top 5 Most Recently Viewed Articles

Samer Alkhaldi Joins HFM to Drive Business Growth in MENA Region

Updated Category News Views 65

Samer Alkhaldi Takes Charge at HFM for MENA Development In an exciting development for HFM, a prominent player in global online trading, Samer Alkhaldi has been appointed as the new Regional Head of Business Development for the MENA region. With an extensive background in the financial sector, Samer’s appointment is a significant strategy to expand and improve services...

Continue Reading
Kenyan Government's Strategic Shift Towards Digital Operations

Updated Category News Views 286

Kenya's Digital Transformation with Danish F2 Platform The Kenyan government is embarking on an exciting journey towards digital transformation by adopting the Danish F2 platform. This innovative initiative was shared by the Ministry of Information, Communications, and the Digital Economy, aiming to streamline processes across various governmental departments. Objective...

Continue Reading
Brookfield Corporation Plans Upcoming Investor Day Event

Updated Category News Views 210

Brookfield Corporation's Investor Day Announcement Brookfield Corporation (NYSE: BN, TSX: BN) and Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM) are gearing up for a significant Investor Day scheduled for a Wednesday in New York. This event aims to engage investors with insights on the company's strategic direction and performance metrics. Event Details The...

Continue Reading
Virtune Updates on MarketVector's Pricing Changes for ETPs

Updated Category News Views 155

Virtune Announces Important Pricing Update for ETPs Virtune, a leading player in digital asset management, has shared significant news regarding its approach to the pricing of its exchange-traded products (ETPs). Effective December 4, 2025, the company will update its reference price provider MarketVector, switching the underlying price source for its crypto assets used...

Continue Reading
Accessible Healthcare Support for Wildfire Affected Residents

Updated Category News Views 157

Virtual Healthcare Appointments for Affected Residents In light of the recent wildfires in Southern California, those who have faced displacement or adversity due to these events can now access more no-cost virtual healthcare appointments. This initiative is expanding to ensure that residents in Los Angeles can receive urgent medical attention, including vital services...

Continue Reading